Advertisement
Incorporation of a genetic risk score can improve the accuracy of colorectal cancer risk determination

Model Including CRC Risk Alleles Ups Risk Discrimination

0
Model more accurately determines risk of colorectal cancer; defines recommended screening age
Nine states have enacted the Interstate Medical Licensure Compact law

Interstate Medical Licensure Compact Formed

0
Formation of compact commission triggered by enactment of law in seventh state: Alabama
Adding to the debate about the benefits of mammography screening before age 50

Limited Evidence for Screening Mammography for Women in 40s

0
But conclusion wasn't unanimous, one expert says
Patients with stage IIIB non-small-cell lung cancer could live longer by undergoing surgical resection

Surgery Deemed Fitting for Some Stage IIIB NSCLC Patients

0
Longer overall survival in patients undergoing surgical resection, compared to chemo-radiation only
Melanoma incidence has increased by 253 percent among U.S. children and young adults since the 1970s

ASCO: Melanoma Rates on the Rise for U.S. Youth

0
Women account for two-thirds of cases, likely due to unsafe tanning
The prices hospitals charge patients for a number of common procedures rose more than 10 percent between 2011 and 2013

CMS: Hospital Charges for Common Procedures Up

0
And hematologists/oncologists and ophthalmologists top list of high earners
Surgery for low-grade ductal carcinoma in situ does not significantly improve outcomes for patients

Surgery for Low-Grade DCIS May Not Improve Survival

0
No difference found in survival for women with low-grade DCIS who did or did not have surgery
Breastfeeding is associated with a reduced risk of childhood leukemia compared to the risk for children who were never breastfed

Breastfeeding Tied to Lower Odds of Childhood Leukemia

0
One more potential benefit for breastfed babies, research suggests
Mortality rates among five-year childhood cancer survivors 15 years after diagnosis have been halved since the 1970s -- falling from 12.4 to 6 percent

ASCO: Longevity Improving for Childhood Cancer Survivors

0
Fewer die of 'late effects' from radiation, chemotherapy
The drug elotuzumab reduces the risk of cancer progression and mortality by 30 percent when combined with the standard two-drug therapy for multiple myeloma

ASCO: Elotuzumab Shows Benefit in Multiple Myeloma

0
Survival gains when elotuzumab was added to treatment